Acute Hypoxia Modifies CAMP Levels Induced by Inhibitors of Phosphodiesterase-4 in Rat Carotid Bodies, Carotid Arteries and Superior Cervical Ganglia

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2010 Jan 20

PMID 20082613

Citations 9

Authors

Ana R Nunes

Joana R Batuca

Emilia C Monteiro

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Phosphodiesterase (PDE) inhibitors are useful to treat hypoxia-related diseases and are used in experiments studying the effects of oxygen on 3'-5'-cyclic adenosine monophosphate (cAMP) production. We studied the effects of acute hypoxia on cAMP accumulation induced by PDE inhibitors in oxygen-specific chemosensors, the carotid bodies (CBs) and in non-chemosensitive CB-related structures: carotid arteries (CAs) and superior cervical ganglia (SCG).

Experimental Approach: Concentration-response curves for the effects of a non-specific PDE inhibitor [isobutylmethylxanthine (IBMX) ], PDE4 selective inhibitors (rolipram, Ro 20-1724) and a PDE2 selective inhibitor (erythro-9-(2-hydroxy-3-nonyl)adenine) on cAMP levels were obtained in normoxic (20% O(2)/5% CO(2)) or hypoxic (5% O(2)/5% CO(2)) conditions.

Key Results: Responses to the PDE inhibitors were compatible with the presence of PDE4 in rat CBs, CAs and SCG but in the absence of PDE2 in CAs and CBs. Acute hypoxia enhanced the effects of IBMX and PDE4 inhibitors on cAMP accumulation in CAs and CBs. In SCG, acute hypoxia reduced cAMP accumulation induced by all the four PDE inhibitors tested. Differences between the effects of Ro 20-1724 and rolipram on cAMP were found in CAs and CBs during hypoxia.

Conclusions And Implications: The effects of PDE4 inhibitors could be potentiated or inhibited by acute hypoxia depending on the PDE isoforms of the tissue. The similarities between the characterization of PDE4 inhibitors at the CBs and CAs, under normoxia and hypoxia, did not support a specific role for cAMP in the oxygen-sensing machinery at the CB and suggested that no direct CB-mediated, hyperventilatory, adverse effects would be expected with administration of PDE4 inhibitors.

Citing Articles

Hypoxia sensing requires HS-dependent persulfidation of olfactory receptor 78.

Peng Y, Nanduri J, Wang N, Kumar G, Bindokas V, Paul B Sci Adv. 2023; 9(27):eadf3026.

PMID: 37406126 PMC: 10321732. DOI: 10.1126/sciadv.adf3026.

The superior cervical ganglia modulate ventilatory responses to hypoxia independently of preganglionic drive from the cervical sympathetic chain.

Getsy P, Coffee G, Hsieh Y, Lewis S J Appl Physiol (1985). 2021; 131(2):836-857.

PMID: 34197230 PMC: 8409919. DOI: 10.1152/japplphysiol.00216.2021.

Loss of Cervical Sympathetic Chain Input to the Superior Cervical Ganglia Affects the Ventilatory Responses to Hypoxic Challenge in Freely-Moving C57BL6 Mice.

Getsy P, Coffee G, Hsieh Y, Lewis S Front Physiol. 2021; 12:619688.

PMID: 33967819 PMC: 8100345. DOI: 10.3389/fphys.2021.619688.

Endogenous sulfur dioxide is a novel inhibitor of hypoxia-induced mast cell degranulation.

Zhang L, Jin H, Song Y, Chen S, Wang Y, Sun Y J Adv Res. 2021; 29:55-65.

PMID: 33842005 PMC: 8020161. DOI: 10.1016/j.jare.2020.08.017.

β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced by chronic intermittent hypoxia.

Alzahrani A, Cao L, Aldossary H, Nathanael D, Fu J, Ray C Pflugers Arch. 2020; 473(1):37-51.

PMID: 33210151 PMC: 7782391. DOI: 10.1007/s00424-020-02492-0.

References

Batuca J, Monteiro T, Monteiro E . Contribution of dopamine D2 receptors for the cAMP levels at the carotid body. Adv Exp Med Biol. 2003; 536:367-73. DOI: 10.1007/978-1-4419-9280-2_48. View

Wang P, Myers J, Wu P, Cheewatrakoolpong B, Egan R, Billah M . Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun. 1997; 234(2):320-4. DOI: 10.1006/bbrc.1997.6636. View

Bender A, Beavo J . Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006; 58(3):488-520. DOI: 10.1124/pr.58.3.5. View

Mokashi A, Di Guilio C, Morelli L, Lahiri S . Chronic hyperoxic effects on cat carotid body catecholamines and structure. Respir Physiol. 1994; 97(1):25-32. DOI: 10.1016/0034-5687(94)90009-4. View

Perez-Garcia M, Almaraz L, Gonzalez C . Effects of different types of stimulation on cyclic AMP content in the rabbit carotid body: functional significance. J Neurochem. 1990; 55(4):1287-93. DOI: 10.1111/j.1471-4159.1990.tb03137.x. View

Millen J, MacLean M, Houslay M . Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells. Eur J Cell Biol. 2006; 85(7):679-91. DOI: 10.1016/j.ejcb.2006.01.006. View

Palmer D, Tsoi K, Maurice D . Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ Res. 1998; 82(8):852-61. DOI: 10.1161/01.res.82.8.852. View

Daly J, Hide I, Muller C, Shamim M . Caffeine analogs: structure-activity relationships at adenosine receptors. Pharmacology. 1991; 42(6):309-21. DOI: 10.1159/000138813. View

Murtaugh T, Bhalla R . Multiple forms of cyclic nucleotide phosphodiesterase from bovine carotid artery smooth muscle. Arch Biochem Biophys. 1979; 196(2):467-74. DOI: 10.1016/0003-9861(79)90298-4. View

10.

Mir A, McQueen D, Pallot D, Nahorski S . Direct biochemical and neuropharmacological identification of dopamine D2-receptors in the rabbit carotid body. Brain Res. 1984; 291(2):273-83. DOI: 10.1016/0006-8993(84)91259-9. View

11.

Jeon Y, Heo Y, Kim C, Hyun Y, Lee T, Ro S . Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci. 2005; 62(11):1198-220. PMC: 11139162. DOI: 10.1007/s00018-005-4533-5. View

12.

Thompson W, Ashikaga T, Kelly J, Liu L, Zhu B, Vemavarapu L . Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). Biochem Pharmacol. 2002; 63(4):797-807. DOI: 10.1016/s0006-2952(01)00914-5. View

13.

Delpiano M, Acker H . Hypoxia increases the cyclic AMP content of the cat carotid body in vitro. J Neurochem. 1991; 57(1):291-7. DOI: 10.1111/j.1471-4159.1991.tb02127.x. View

14.

Conde S, Monteiro E . Hypoxia induces adenosine release from the rat carotid body. J Neurochem. 2004; 89(5):1148-56. DOI: 10.1111/j.1471-4159.2004.02380.x. View

15.

Alexander S, Mathie A, Peters J . Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol. 2008; 153 Suppl 2:S1-209. PMC: 2275471. DOI: 10.1038/sj.bjp.0707746. View

16.

Perez-Garcia M, Almaraz L, Gonzalez C . Cyclic AMP modulates differentially the release of dopamine induced by hypoxia and other stimuli and increases dopamine synthesis in the rabbit carotid body. J Neurochem. 1991; 57(6):1992-2000. DOI: 10.1111/j.1471-4159.1991.tb06414.x. View

17.

Podzuweit T, Nennstiel P, Muller A . Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell Signal. 1995; 7(7):733-8. DOI: 10.1016/0898-6568(95)00042-n. View

18.

Pauvert O, Salvail D, Rousseau E, Lugnier C, Marthan R, Savineau J . Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery. Biochem Pharmacol. 2002; 63(9):1763-72. DOI: 10.1016/s0006-2952(02)00919-x. View

19.

Chen J, Dinger B, Fidone S . cAMP production in rabbit carotid body: role of adenosine. J Appl Physiol (1985). 1997; 82(6):1771-5. DOI: 10.1152/jappl.1997.82.6.1771. View

20.

Nunes A, Batuce J, Monterio E . Functional characterization of phosphodiesterases 4 in the rat carotid body: effect of oxygen concentrations. Adv Exp Med Biol. 2009; 648:113-9. DOI: 10.1007/978-90-481-2259-2_13. View